Thoroughbred Financial Services’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.1M | Buy |
9,930
+5,288
| +114% | +$586K | 0.08% | 245 |
|
|
2025
Q1 | $520K | Buy |
+4,642
| New | +$520K | 0.03% | 413 |
|
|
2024
Q1 | – | Sell |
-2,680
| Closed | -$217K | – | 529 |
|
|
2023
Q4 | $217K | Buy |
+2,680
| New | +$217K | 0.02% | 552 |
|
|
2020
Q3 | – | Sell |
-2,907
| Closed | -$224K | – | 231 |
|
|
2020
Q2 | $224K | Sell |
2,907
-617
| -18% | -$47.5K | 0.09% | 199 |
|
|
2020
Q1 | $263K | Buy |
3,524
+416
| +13% | +$31K | 0.09% | 192 |
|
|
2019
Q4 | $202K | Sell |
3,108
-3,131
| -50% | -$203K | 0.07% | 238 |
|
|
2019
Q3 | $395K | Sell |
6,239
-642
| -9% | -$40.6K | 0.15% | 160 |
|
|
2019
Q2 | $465K | Sell |
6,881
-5,762
| -46% | -$389K | 0.18% | 123 |
|
|
2019
Q1 | $822K | Sell |
12,643
-144
| -1% | -$9.36K | 0.34% | 85 |
|
|
2018
Q4 | $799K | Buy |
+12,787
| New | +$799K | 0.39% | 77 |
|